|Publication number||USRE30912 E|
|Application number||US 05/915,451|
|Publication date||Apr 27, 1982|
|Filing date||Jun 14, 1978|
|Priority date||Sep 16, 1968|
|Publication number||05915451, 915451, US RE30912 E, US RE30912E, US-E-RE30912, USRE30912 E, USRE30912E|
|Inventors||Warren D. Hancock|
|Original Assignee||Hancock Laboratories, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (4), Non-Patent Citations (10), Referenced by (60), Classifications (5), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This invention relates to a supporting framework, or stent, for a natural or synthetic heart valve.
At the present time, surgical techniques allow the transplanting of aortic valves in the hearts of human patients, where they are located in either the aortic or mitral position. In such an operation, a natural valve from an animal or human, or alternatively a synthetic valve, is implanted in the heart. There exists, however, the need for an improved means for securing and supporting the valve in the heart to assure its proper functioning and to avoid clotting or other difficulties. In addition, there has been lacking a suitable means for preparing natural heart valves in advance for implantation so that they may be stored until the requirement for use arises.
The present invention provides a stent for natural or synthetic heart valves that results in an improved means for supporting and grafting the heart valve in the patient. This invention makes possible the preparation of natural heart valves, such as those from animals or from humans, which are applied to the stents under controlled conditions and may be stored suitably so that an adequate supply of the heart valves may be maintained.
The stent is usable for valves to be used in both the aortic and mitral positions. It comprises a frame of generally tubular configuration that includes three arcuate apexes interconnected by support arms. The apexes are positioned at the approximate locations of the aortic commissures. By having an arcuate contour, they have a finite dimension in a direction circumferential of the stent, so that dimension variations in the valves may be accommodated. Upper and lower support arms interconnect the apexes, being scalloped to extend downwardly intermediate the apexes. Both serve as a means for securing the perimeter of the valve cusps to the stent by suturing or other appropriate means. Preferably, the stent is of deflectable material, such as stainless steel having some malleability, so that the upper support arms may be bent upwardly. By virtus of their scalloped shape, this increases the spacing of the arms from the central axis of the stent, so that the stent may be increased in width to fit individual valves of different configurations. The scalloped shape of the upper arms also allows placement of the valve in the aortic position without obstructing the coronary ostia.
When the stent is used for valves that are to be installed in the mitral position, it may be provided with a ring outwardly of the lower support arms. This ring provides a means for affixing the stent to the heart. A felt ring is secured to the stent at the location of the attaching ring, providing a hemodynamic seal and a suitable bed over which tissue can be attached. The mitral leaflet and endocardium are brought over the atrial aspect of the attaching ring and affixed to the felt ring.
Thus, as either version of the stent is used, there is no exposure of metal to the portions of the heart where clotting is a problem, and with only tissue exposed to the blood in the critical areas tendencies toward clotting are minimized.
An object of this invention is to provide an improved stent for natural or synthetic heart valves.
Another object of this invention is to provide a heart valve stent that can accommodate valves of different dimensions.
A further object of this invention is to provide an arrangement by which a heart valve is supported on a stent and secured so that only tissue or other material that does not promote the formation of clots will be exposed in critical areas of the heart when clotting might occur.
An additional object of this invention is to provide a stent that permits advance preparation under controlled conditions of heart valves which may be stored under suitable conditions until required.
A still further object of this invention is to provide a stent contoured to accommodate animal heart valves for use in xenografts.
These and other objects will become apparent from the following detailed description taken in connection with the accompanying drawing.
FIG. 1 is a perspective view of the stent of this invention constructed for use in the aortic position;
FIG. 2 is an enlarged fragmentary sectional view taken along line 2--2 of FIG. 1, illustrating the rounded cross-sectional contour of the elements of the stent;
FIG. 3 is a perspective view, partialy broken away, showing the stent of FIG. 1 with an aortic valve affixed thereto;
FIG. 4 is a side elevational view of the stent, showing how the support arms may be deflected for increasing the transverse dimension;
FIG. 5 is a perspective view of the stent constructed for use in the mitral position;
FIG. 6 is a perspective view, partially broken away, of an assembly of the stent of FIG. 5 and a heart valve;
FIG. 7 is a perspective view, partially broken away, illustrating a modified attachment of the heart valve to the stent;
FIG. 8 is an enlarged sectional view taken along line 8--8 of FIG. 7;
FIG. 9 is a sectional view similar to FIG. 8 with the addition of a ring around the outer perimeter of the assembly;
FIG. 10 is a view similar to FIG. 9, but in which a cloth member has been applied over the stent prior to attachment of the heart valve;
FIG. 11 is a perspective view, partially broken away, of a heart valve assembly for use in the mitral position in which a cloth covering is provided over certain marginal portions;
FIG. 12 is a perspective view of a heart valve for use in the mitral position in which there is a cloth attaching ring instead of a metal ring; and
FIG. 13 is an enlarged sectional view taken along line 13--13 of FIG. 12.
The stent 10, shown in FIGS. 1, 2 and 3, is for use in the aortic or pulmonary location. It constitutes an annular framework, circular in plan, that may be constructed of noncorrosive metal, such as stainless steel, or of plastic. When made of metal, it should have some malleability which permits the device to be deflected to alter its shape slightly from that illustrated. This has the advantage of allowing it to accommodate valves of different dimensions, as will be explained below. Preferably, the metal stent is produced from a single piece of material. This avoids any welded, brazed or other connections, eliminating the likelihood of galvanic corrosion after it has been implanted. All portions of the stent are rounded at their edges so that no sharp corners are presented (see FIG. 2).
The stent 10 includes three apical portions 11, 12 and 13, which are of generally oval shape including rounded upper portions. The central areas 14, 15 and 16 of the apical portions 11, 12 and 13 are cut away. Particularly when the stent is intended for use with animal valves, the apical portions are not distributed evenly around the perimeter of the stent 10. There is an equal angular spacing between the apical portions 11 and 12, and between the apical portions 12 and 13. However, the spacing between the apical portions 11 and 13 is less than that between the other two adjoining apexes. Usually, the spacing between the apexes 11 and 13 is within the range of approximately 17% to 33% under the spacing of the other apexes, preferably around 20% to 25% less. This is in order that the stent will conform to the spacing of the commissures of the valve to be applied to it, which, for animals, is very close to this proportioning.
Interconnecting the lower sides of the apical portions 11, 12 and 13 are upper support bars 18, 19 and 20. These are scalloped, being curved away from the apical portions 11, 12 and 13 so that they are concave toward the end of the stent where the apical parts are located.
Beneath the apexes 11, 12 and 13, as the device is illustrated, are short depending posts 22, 23 and 24 which extend parallel to the axis of the stent 10. To these posts are attached lower support arms 25, 26 and 27. The latter elements are shaped generally the same as the upper support arms 18, 19 and 20 and are spaced an equivalent distance from the stent axis. Again, therefore, the lower support arms are of scalloped configuration, being inclined downwardly intermediate the support posts. However, the lower support arms 25, 26 and 27 are not scalloped as deeply as are the upper arms.
As shown in FIG. 3, an animal aortic valve 28 is associated with the stent 10 for use in a xenograft. The valve 28 is secured to the stent by appropriate means, such as sutures 29. The valve commissures are positioned at the apexes, while the margins of the cusps conform to the scalloped configuration of the support arms. The marginal portions 30 and 31 of the valve cusps are extended over the support arms of the stent and overlap them, being doubled over the stent where the attachments are made. Consequently, the stent 10 is covered after the valve 28 is affixed.
The presence of the various apexes and support arms assures that there is a portion of the stent conforming to the shape of the valve 28 that is available for secure attachment of all peripheral parts of the valve. The arcuate upper portions of the apexes 11, 12 and 13 allow latitude in positioning of the commissures of the valve. There are some dimensional differences among all natural valves, and the spacing of the commissures may vary to some degree. With the upper portions of the apexes 11, 12 and 13 being arcuate, valves of different proportions may be accommodated and allowed to assume their natural contour while still being afforded ready and appropriate locations for attachment. In other words, if the spacing of the commissures does not correspond exactly to the distances between the centers of the apexes, the commissures nevertheless may be affixed to side portions of the apexes and thereby supported properly and in conformance with the natural valve contour.
Another advantage lies in the scalloped configuration and deflectable characteristics of the upper support arms 18, 19 and 20. By bending the support arm upwardly, as indicated in phantom in FIG. 4, the spacing of the arm from the central axis of the stent 10 becomes increased. Therefore, for valves of larger dimensions or those of irregular proportions, the arms may be deflected as required to assure that the stent provides the precise fit needed for the valve. Accordingly, the stent may be given an exact configuration to conform to the individual valve being assoicated with it. The upper arms 18, 19 and 20 are scalloped more deeply than are the lower support arms to provide for a maximum amount of dimensional variation upon deflection of the upper arms.
This advantage is realized with stents of metal construction in which the upper support arms may be deflected. This does not hold true, however, for stents made of plastic, as suitable plastics cannot be bent to assume different shapes permanently. The scalloped configuration of the upper support arms not only makes dimensional changes possible, but also allows placement of the valve in the aortic position without obstructing the coronary ostia.
The stent 32 shown in FIG. 5, for mitral or tricuspid location, has the same general configuration as the aortic stent, but is of larger and slightly heavier construction. Additionally, it includes an outer ring, which is used in securing the stent to the heart.
The stent 32, as illustrated, includes rounded apexes 33, 34 and 35, each being cut away interiorly so as to be of annular and generally oval configuration. Downwardly scalloped upper support arms 36, 37 and 38 interconnect the apexes. Beneath the upper arms are similarly shaped but more shallowly scalloped lower support arms 40, 41 and 42. These connect at their ends to posts 43, 44 and 45 that extend below the apexes 33, 34 and 35, respectively.
Additional short posts 46, 47 and 48 extend downwardly, as the device is shown, from the junctures between the adjacent lower support arms 40, 41 and 42. At their upper ends, the posts 46, 47 and 48 are generally parallel to the axis. The bottom portions of the posts 46, 47 and 48, however, are bent substantially at right angles to extend generally radially to an outer attaching ring 50. The latter element is circular and of greater diameter than the annulus defined by the support arms.
The attachment of the valve 51 to the stent 32 for the mitral position is essentially the same as that of the valve 28 to the aortic stent 10. Again, suturing 52 normally is employed to effect the attachment of the marginal portions of the valve 51. In addition, however, an annular member 53 of felt or other suitable material is positioned around the stent 32 between the outer ring 50 and the annular structure provided by the posts 46, 47 and 48 and the lower arms 40, 41 and 42. The felt ring 53 provides a hemodynamic seal and a suitable bed over which tissue can be affixed. The mitral leaflet and the endocardium 54 are brought over the atrial aspect of the outer ring 50 (i.e., the end remote from the apexes) and affixed by sutures to the felt ring 53. This serves an important function in the prevention of blood clots. The ring 50 and other parts of the stent 32 are completely covered in the portions of the assembly that are positioned in localities of the heart where clotting is likely to take place. Therefore, in the critical zones of the heart where a thrombus may occur, any exposure of material that might promote clotting is minimized. The ring 50 provides a stable and secure means for affixing the stent and associated mitral valve to the heart. This is accomplished normally by sutures to attach the valve in the mitral position between the left atrium and ventricle.
Various modifications may be made in the manner in which the heart valve is mounted on the stent. For example, as shown in FIGS. 7 and 8, the heart valve 55 attached to the aortic stent 10 is not doubled over the upper perimeter of the stent. In other words, the upper margin of the heart valve is not arranged as illustrated in FIG. 3, where the margin 31 is shown doubled over the upper arms 18, 19 and 20 and the apexes 11, 12 and 13. Instead, the margin 56 of the heart valve 55 of FIGS. 7 and 8 is allowed to project beyond the stent to provide a free edge portion of tissue. Inwardly of this, sutures 57 secure the upper part of the heart valve to the stent. The marginal edge portion 56 provides a flap of material which may be used in attaching the heart valve 55 to the heart wall. This technique is preferred in some instances.
The arrangement of FIG. 9 is similar to that of FIG. 8 except that a ring has been added around the perimeter of the stent. This is an annular member, normally of a suitable cloth such as felt, or of sponge, held in place by sutures and extending around the exterior of the support arms below the apexes of the stent. This ring provides a suitable bed for fibrous ingrowth after the grafting of the valve in the heart. This also provides a compliant member capable of conforming to an irregular aortic root to assure a snug fit and a hemodynamic seal. Moreover, the annulus of the valve supported on the stent often is irregular, further adding to the desirability of the exteriorly applied member in such instances.
While illustrated in FIG. 9 in conjunction with an attachment of the heart valve to leave a free marginal flap 56, the ring 58 also is applicable when the heart valve is attached upon a doubling over of the tissue as indicated in FIG. 3. The ring 58 may be used on either the stent 10 for the aortic position or the stent 32 for the mitral position.
FIG. 10 illustrates a further modification in which an annular cloth element 60 is provided on the stent prior to attachment of the heart valve. The cloth 60 is, in effect, tubular in shape, providing a sleeve that has a continuous transverse wall which overlaps and receives the upper and lower arms of the stent. However, the annular cloth member 60 does not extend over the stent apexes. Normally, a ring 58 will be utilized in conjunction with an assembly that embodies the annular cloth element 60. This cloth covering of the inner and outer stent surfaces, which can be applied to either the aortic or the mitral stent, provides a means by which the tissue is more easily attached to the stent. It results also in a matrix for ingrowth and subsequent fixation of the donor valve by the host tissue.
In FIG. 11, there is illustrated a heart valve 51 on the stent 32 for use in the mitral position similar to the arrangement of FIG. 6 but with a cloth layer 62 added over the periphery of the stent and inwardly of the outer ring 50. The layer of cloth 62 follows the contour of the stent and is fixed in place by sutures. The cloth layer 62 adds a matrix for fibrous ingrowth, facilitating the binding of the host tissue to the graft tissue. It also covers the sutures and the ragged edges of the margins of the heart valve that overlap the framework of the stent, providing an assembly of an improved neat appearance.
In the arrangement of FIGS. 12 and 13, the stent is intended for use in the mitral position, but is constructed without the metal ring 50 around its periphery. Instead, a cloth ring is provided, which serves a similar purpose, providing a means for attachment to the heart. The stent 63 shown in FIG. 12 is similar to the stent 32 in that it is provided with a comparable grouping of apexes and support arms, and larger and heavier than the stents for use in the aortic position. Thus, there are apexes 64, 65 and 66 interconnected by downwardly scalloped upper arms 67, 68 and 69 beneath which are lower arms 70, 71 and 72. Extending around the bottom periphery of the stent is a cloth ring 73. This is of doubled-over construction, with the lower arms 70, 71 and 72 received inside it. The outer edge, where the attachment is made to complete the double-walled cloth construction, is inwardly folded, as seen in FIG. 13. At the locations of the posts 75, 76 and 77, where the lower arms are connected to the upper portion of the stent, it is necessary to omit the outer layer of the cloth ring 73, as shown in FIG. 12.
It is to be remembered that the heart has four primary valves: two of which carry the blood away from the heart, the aortic and pulmonary valves; and two atrioventricular valves, the mitral and tricuspid valves. Since the aortic and pulmonary valves are similar in configuration as are the mitral and tricuspid valves, and since the device referred to herein as an aortic valve stent is equally suited to the pulmonary location, it is to be understood that the terms aortic and mitral are descriptive of the type of application and are not restrictive to a particular anatomic location.
The present invention also comprehends a device in which the spacings between the various apical portions are all unequal (each space being different from each other space). Using one space as the reference the second is approximately 4-10% less than said reference (space), and the third space is 17% to 33% less than said reference (space).
It is to be understood that cloth may be used to cover the frame in any one of a number of configurations. The cloth may be a seamless cylinder, or flat stock cut, formed and seamed, or specially preformed material. The methods described previously in this specification are by way of specific illustration.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3365728 *||Dec 18, 1964||Jan 30, 1968||Edwards Lab Inc||Upholstered heart valve having a sealing ring adapted for dispensing medicaments|
|US3445916 *||Apr 19, 1967||May 27, 1969||Schulte Rudolf R||Method for making an anatomical check valve|
|US3466671 *||Oct 19, 1966||Sep 16, 1969||Edwards Lab Inc||Heart valve prosthesis having a cloth covered body|
|SU158988A1 *||Title not available|
|1||*||"A Method for Placing a Total Homologous Aortic Valve in Subcoronary Position" by Duran and Gunning, The Lancet, Sep. 8, 1962, pp. 488 and 489.|
|2||*||"A Method for Preparing and Inserting a Homograft Aortic Valve" by B. G. Barratt-Boyes, British Journal of Surgery, vol. 52, No. 11, Nov. 1965, pp. 847-856.|
|3||*||"A Prefabricated Semirigid Tricusp Aortic Valve Prosthesis" by E. Hessel et al., Journal of Thoracic & Cardiovascular Surgery, vol. 54, No. 2, Aug. 1967, pp. 227-245.|
|4||*||"A Prosthetic Stented Aortic Homograft for Mitral Valve Replacement" by C. Weldon et al., Journal of Surgical Research, vol. 6, No. 12, Dec. 1966, pp. 548-553.|
|5||*||"Fixation of Aortic Valve Homografts with Metal Rings" by A. S. Geha et al., The Journal of Thoracic & Cardiovascular Surgery, vol. 54, No. 5, pp. 605-615, Nov. 1967.|
|6||*||"Homograft Aortic Valve Replacement in Aortic Incompetence and Stenosis" by B. G. Barratt-Boyes, Thorax (1964), 19, pp. 131-150.|
|7||*||"Memoires de l'Academie de Chirurgie" published Jun. 1967, vol. 93, No. 19-20-21, pp. 617-622, by A. Carpentier et al.|
|8||*||"Mitral Valve Replacement with Aortic Heterografts in Humans" by M. I. Ionescu et al., Thorax, vol. 22, No. 4, Jul. 1967, pp. 305-313.|
|9||*||"Replacement of the Mitral Valvular Apparatus by Hetertopic Heterografts" by A. Carpentier et al., La Presse Medicale, Jun. 24, 1967, 75-No. 31, pp. 1603-1606.|
|10||*||"Simplified Insertion of Aortic Homograft Valves with _Nonthrombogenic Frames" by N. Braunwald et al., Transactions, American Society for Artificial Internal Organs, vol. XIII, Jun. 16, 1967, pp. 111-115.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5116564 *||Oct 10, 1989||May 26, 1992||Josef Jansen||Method of producing a closing member having flexible closing elements, especially a heart valve|
|US5376113 *||Dec 21, 1993||Dec 27, 1994||Jansen; Josef||Closing member having flexible closing elements, especially a heart valve|
|US5928281 *||Mar 27, 1997||Jul 27, 1999||Baxter International Inc.||Tissue heart valves|
|US6585766||Jun 22, 2000||Jul 1, 2003||Edwards Lifesciences Corporation||Cloth-covered stents for tissue heart valves|
|US6761735||Apr 25, 2002||Jul 13, 2004||Medtronic, Inc.||Heart valve fixation process and apparatus|
|US7018403||Sep 14, 2004||Mar 28, 2006||Advanced Cardiovascular Systems, Inc.||Inclined stent pattern for vulnerable plaque|
|US7819915||Oct 26, 2010||Edwards Lifesciences Corporation||Heart valve holders and handling clips therefor|
|US7951197||May 31, 2011||Medtronic, Inc.||Two-piece prosthetic valves with snap-in connection and methods for use|
|US7959674||Jun 14, 2011||Medtronic, Inc.||Suture locking assembly and method of use|
|US7967857||Jun 28, 2011||Medtronic, Inc.||Gasket with spring collar for prosthetic heart valves and methods for making and using them|
|US7972377||Aug 29, 2008||Jul 5, 2011||Medtronic, Inc.||Bioprosthetic heart valve|
|US7981153||Jul 19, 2011||Medtronic, Inc.||Biologically implantable prosthesis methods of using|
|US8021161||May 1, 2006||Sep 20, 2011||Edwards Lifesciences Corporation||Simulated heart valve root for training and testing|
|US8021421||Sep 20, 2011||Medtronic, Inc.||Prosthesis heart valve fixturing device|
|US8025695||Sep 27, 2011||Medtronic, Inc.||Biologically implantable heart valve system|
|US8211169||Jul 3, 2012||Medtronic, Inc.||Gasket with collar for prosthetic heart valves and methods for using them|
|US8308798||Nov 13, 2012||Edwards Lifesciences Corporation||Quick-connect prosthetic heart valve and methods|
|US8348998||Jan 8, 2013||Edwards Lifesciences Corporation||Unitary quick connect prosthetic heart valve and deployment system and methods|
|US8349003||Apr 12, 2011||Jan 8, 2013||Medtronic, Inc.||Suture locking assembly and method of use|
|US8449625||May 28, 2013||Edwards Lifesciences Corporation||Methods of measuring heart valve annuluses for valve replacement|
|US8460373||Jul 1, 2011||Jun 11, 2013||Medtronic, Inc.||Method for implanting a heart valve within an annulus of a patient|
|US8500802||Mar 8, 2011||Aug 6, 2013||Medtronic, Inc.||Two-piece prosthetic valves with snap-in connection and methods for use|
|US8506625||Aug 9, 2010||Aug 13, 2013||Edwards Lifesciences Corporation||Contoured sewing ring for a prosthetic mitral heart valve|
|US8518108||Aug 12, 2005||Aug 27, 2013||Edwards Lifesciences Corporation||Contoured heart valve suture rings|
|US8551162||Dec 20, 2002||Oct 8, 2013||Medtronic, Inc.||Biologically implantable prosthesis|
|US8574257||Aug 10, 2009||Nov 5, 2013||Edwards Lifesciences Corporation||System, device, and method for providing access in a cardiovascular environment|
|US8603159 *||Dec 11, 2009||Dec 10, 2013||Medtronic Corevalve, Llc||Prosthetic valve for transluminal delivery|
|US8603161||Jul 6, 2009||Dec 10, 2013||Medtronic, Inc.||Attachment device and methods of using the same|
|US8623080||Sep 22, 2011||Jan 7, 2014||Medtronic, Inc.||Biologically implantable prosthesis and methods of using the same|
|US8641757||Jun 23, 2011||Feb 4, 2014||Edwards Lifesciences Corporation||Systems for rapidly deploying surgical heart valves|
|US8696742||Oct 10, 2012||Apr 15, 2014||Edwards Lifesciences Corporation||Unitary quick-connect prosthetic heart valve deployment methods|
|US8747463||Aug 3, 2011||Jun 10, 2014||Medtronic, Inc.||Methods of using a prosthesis fixturing device|
|US8801779||May 10, 2011||Aug 12, 2014||Medtronic Corevalve, Llc||Prosthetic valve for transluminal delivery|
|US8821569||Apr 30, 2007||Sep 2, 2014||Medtronic, Inc.||Multiple component prosthetic heart valve assemblies and methods for delivering them|
|US8845720||Sep 20, 2011||Sep 30, 2014||Edwards Lifesciences Corporation||Prosthetic heart valve frame with flexible commissures|
|US8986374||May 10, 2011||Mar 24, 2015||Edwards Lifesciences Corporation||Prosthetic heart valve|
|US9005277||Dec 21, 2012||Apr 14, 2015||Edwards Lifesciences Corporation||Unitary quick-connect prosthetic heart valve deployment system|
|US9005278||Oct 25, 2012||Apr 14, 2015||Edwards Lifesciences Corporation||Quick-connect prosthetic heart valve|
|US9078747||Nov 13, 2012||Jul 14, 2015||Edwards Lifesciences Corporation||Anchoring device for replacing or repairing a heart valve|
|US9125741||Mar 12, 2013||Sep 8, 2015||Edwards Lifesciences Corporation||Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves|
|US9155617||Apr 18, 2014||Oct 13, 2015||Edwards Lifesciences Corporation||Prosthetic mitral valve|
|US9248016||Mar 3, 2010||Feb 2, 2016||Edwards Lifesciences Corporation||Prosthetic heart valve system|
|US9333078||Nov 22, 2013||May 10, 2016||Medtronic, Inc.||Heart valve assemblies|
|US9370418||Mar 12, 2013||Jun 21, 2016||Edwards Lifesciences Corporation||Rapidly deployable surgical heart valves|
|US20040138741 *||Dec 19, 2003||Jul 15, 2004||Robert Stobie||Heart valve holders and handling clips therefor|
|US20050228494 *||Mar 29, 2004||Oct 13, 2005||Salvador Marquez||Controlled separation heart valve frame|
|US20060271172 *||May 16, 2006||Nov 30, 2006||Hassan Tehrani||Minimally Invasive Aortic Valve Replacement|
|US20070254273 *||May 1, 2006||Nov 1, 2007||Hugues Lafrance||Simulated heart valve root for training and testing|
|US20090157175 *||Dec 15, 2008||Jun 18, 2009||Edwards Lifesciences Corporation||Leaflet attachment frame for a prosthetic valve|
|US20100063363 *||Mar 11, 2010||Hamman Baron L||System, device, and method for providing access in a cardiovascular environment|
|US20100152840 *||Dec 11, 2009||Jun 17, 2010||Jacques Seguin||Prosthetic Valve for Transluminal Delivery|
|US20100161036 *||Dec 10, 2009||Jun 24, 2010||Edwards Lifesciences Corporation||Quick-connect prosthetic heart valve and methods|
|US20100249894 *||Sep 30, 2010||Edwards Lifesciences Corporation||Prosthetic heart valve system|
|US20100249908 *||Sep 30, 2010||Edwards Lifesciences Corporation||Prosthetic heart valve system with positioning markers|
|US20100331972 *||Jun 23, 2010||Dec 30, 2010||Edwards Lifesciences Corporation||Unitary Quick Connect Prosthetic Heart Valve and Deployment System and Methods|
|US20110054598 *||Aug 9, 2010||Mar 3, 2011||Edwards Lifesciences Corporation||Contoured Sewing Ring for a Prosthetic Mitral Heart Valve|
|US20110098602 *||Apr 28, 2011||Edwards Lifesciences Corporation||Apparatus and Method for Measuring Body Orifice|
|US20110190877 *||Aug 4, 2011||Medtronic, Inc.||Two-Piece Prosthetic Valves with Snap-In Connection and Methods for Use|
|US20140236289 *||Apr 25, 2014||Aug 21, 2014||St. Jude Medical, Inc.||Prosthetic aortic heart valves|
|USRE45130 *||Feb 28, 2001||Sep 9, 2014||Jenavalve Technology Gmbh||Device for fastening and anchoring cardiac valve prostheses|
|U.S. Classification||623/2.18, 623/900|
|Nov 14, 1983||AS||Assignment|
Owner name: EXTRACORPOREAL MEDICAL SPECIALTIES, INC. A PA. COR
Free format text: MERGER;ASSIGNOR:VASCOR INC., A CORP OF CA (INTO);REEL/FRAME:004202/0030
Effective date: 19820104
Owner name: VASCOR INC.
Free format text: CHANGE OF NAME;ASSIGNOR:HANCOCK LABORATORIES INCORPORATED;REEL/FRAME:004202/0026
Effective date: 19800901
|Dec 13, 1985||AS||Assignment|
Owner name: MCNEILAB, INC., 123 S. BROAD STREET, C/O CT CORPOR
Free format text: CHANGE OF NAME;ASSIGNOR:EXTRACORPOREAL MEDICAL SPECIALTIES, INC.;REEL/FRAME:004487/0401
Effective date: 19840920
|Jan 4, 1988||AS||Assignment|
Owner name: MEDTRONIC, INC., 7000 CENTRAL AVENUE, N.E., MINNEA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:MCNEILAB, INC.;REEL/FRAME:004809/0919
Effective date: 19871207